Fingerprint
Dive into the research topics of 'The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer
Pratibha S. Binder, Yassar M. Hashim, James Cripe, Tommy Buchanan, Abigail Zamorano, Suwanna Vangveravong, David G. Mutch, William G. Hawkins, Matthew A. Powell, Dirk Spitzer
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations